From identifying insights with comprehensive genomic profiling to streamlining data interpretation and report generation, Illumina strives to support oncologists by delivering sample-to-report genomic solutions that can help to inform therapy decisions and improve patient outcomes. At ESMO 2025, we have partnered with Pillar Biosciences to highlight our expanding range of NGS-based solutions.
Find us at booth 3023, (Hall 3.2). Speak with the Illumina team to discover how CGP is helping to unlock precision medicine, and learn how Pillar Biosciences is providing rapid NGS solutions to drive actionable, accessible insights to everyone, everywhere.